Issue #310 Nov – 16 Nov 2026

Weekly Science Roundup: Brain Night Cleaning and New Cancer Drug

A summary of key global breakthroughs in neuroscience, oncology, space exploration, and battery tech for the week of November 10 to 16, 2026, alongside SciTamil's deep dives on neuromorphic AI processors, cardiac ApoB risks, and solid-state EV safety.

  • 8Stories
  • 6Topics
  • 8Sources
Neuromorphic edge AI computing microchip architecture inspired by biological neural networks
01Neuroscience

Pink Noise Enhances Brain Fluid Clearance During Sleep

MIT researchers found that timed acoustic bursts of pink noise during slow-wave sleep stimulate cerebrospinal fluid pulses to wash toxic proteins from brain tissue.

Key figureNature Aging

02Neuroscience

Resting Brain Signals Predict Alzheimer's Risk Early

Stanford Medicine scientists developed the ARC connectome score using resting fMRI, identifying vulnerability decades before memory symptoms appear.

Key figureScience Advances

03Medicine

FDA Approves Oral Giredestrant for Advanced Breast Cancer

The FDA approved Roche's oral SERD giredestrant in combination with everolimus for ESR1-mutated ER-positive metastatic breast cancer, reducing progression risk by 62%.

Key figure62%

07Space Science

Euclid Space Telescope Releases 900M-Galaxy Data Trove

ESA's Euclid mission published its DR1 foundation release, mapping over 900 million galaxies and discovering its first comet along with 31 ancient quasars.

Key figure900M+ galaxies

08Space Science

ISRO Successfully Hot-Tests Upgraded PS3 Motor

Following anomalies on two flights, ISRO conducted a full-duration ground test of the redesigned PSLV third stage at SDSC Sriharikota.

Key figureSriharikota

Editor's note

This week brought compelling advances across global science and medicine. MIT neuroscientists demonstrated that acoustic stimulation using gentle pink noise during deep sleep enhances cerebrospinal fluid flow through the brain. This finding offers new therapeutic avenues for reversing age-related decline in brain waste clearance, with direct implications for Alzheimer's prevention.

In clinical oncology, the US FDA granted full approval for giredestrant, an oral selective estrogen receptor degrader (SERD) for ESR1-mutated advanced breast cancer, demonstrating a 62% reduction in disease progression risk. Simultaneously, Stanford researchers revealed that resting-state brain connectivity patterns (the ARC score) can predict Alzheimer's vulnerability years before cognitive symptoms emerge.

In space and physics, the European Space Agency's Euclid mission released its landmark initial dataset mapping over 900 million galaxies and identifying 31 primordial quasars dating back to the cosmic dawn. In India, ISRO completed a crucial ground test of its upgraded PSLV third-stage motor at Sriharikota, setting the stage for the workhorse launcher's return to flight.

Coming next week

  • COP31 Climate Conference outcomes and decarbonization targets
  • ISRO PSLV-C63 return-to-flight mission timeline
  • Euclid DR1 deep cosmic map and primordial black hole analysis
  • Emerging long-term clinical safety data on GLP-1 receptor agonists

All issues

  1. Issue #310 Nov – 16 Nov 2026
  2. Issue #22 Nov – 8 Nov 2026
  3. Issue #126 Oct – 1 Nov 2026

Weekly science news delivered to your inbox

A new edition every week – delivered straight to your inbox.

Unsubscribe anytime. No spam.